| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Boucharlat Gregory | Senior VP, Global Commercial | 200 INNOVATION WAY, AKRON | /s/ Daniel T Young, signing as an attorney-in-fact agent duly authorized to execute this Form 4 on behalf of Gregory Boucharlat pursuant to a Power of Attorney dated 4/30/25, a copy of which has been previously filed with the SEC. | 2025-05-19 | 0002067218 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GT | 2022 Plan Performance Share Units | Award | $0 | +19K | $0.00 | 19K | May 15, 2025 | Common Stock | 19K | Direct | F1 | ||
| transaction | GT | 2022 Plan Restricted Stock Units | Award | $0 | +9.51K | $0.00 | 9.51K | May 15, 2025 | Common Stock | 9.51K | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Performance Share Unit grant under the 2022 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2028. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance goals over a 3-year period ending December 31, 2027, and is subject to increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2027. |
| F2 | Restricted Stock Unit ("RSU") grant under the 2022 Performance Plan. The RSUs will vest and convert into shares of common stock in 33% increments over three years commencing on May 15, 2026. |